PHARMACOECONOMIC ANALYSIS OF THE TREATMENT OF ODONTOGENIC OSTEOMYELITIS

Kozin Dmitry Vladimirovich, Chief doctor of “Alladin” dental clinic, alladin@yandex.ru
Rodina Olesya Petrovna, Candidate of medical sciences, associate professor, sub-department of general and clinical pharmacology, Medical Institute, Penza State University, rodina_pharm@mail.ru
Moiseeva Inessa Yakovlevna, Doctor of medical sciences, professor, head of sub-department of general and clinical pharmacology, Medical Institute, Penza State University, moiseeva_pharm@mail.ru
Ivanov Petr Vladimirovich, Candidate of medical sciences, associate professor, head of sub-department of dentistry, Medical Institute, Penza State University, moiseeva_pharm@mail.ru

616.31-085

It is carried out pharmacoeconomics research therapy of odontogenic osteomyelitis in the Division of Oral Surgery of the Regional clinical hospital of Penza city. It was found that the maximum share of spending on drugs accounts for antibiotics – drugs related to the category of vital in this pathology.

pharmacoeconomics research, odontogenic osteomyelit, antibiotics.